HTA64 A Retrospective Review of NICE Appraisals From 2017-2022 to Investigate the Impact of the New Severity Modifier on Cost-Effectiveness Thresholds Across Multiple Therapy Areas
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.1524
https://www.valueinhealthjournal.com/article/S1098-3015(22)03729-9/fulltext
Title :
HTA64 A Retrospective Review of NICE Appraisals From 2017-2022 to Investigate the Impact of the New Severity Modifier on Cost-Effectiveness Thresholds Across Multiple Therapy Areas
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)03729-9&doi=10.1016/j.jval.2022.09.1524
First page :
Section Title :
Open access? :
No
Section Order :
11068